维普中文期刊产品整合服务
16篇 您的检索式:作者名="Coskunpinar"
    题名 作者 年代 出处 被引量
1Assessment of endothelial function in patients with nonalcoholic fatty liver disease显示文摘Yasar Colak Ebubekir Senates Atakan Yesil Yusuf Yilmaz Oguzhan Ozturk Levent Doganay Ender Coskunpinar Ozlem Timirci Kahraman Banu Mesci Celal Ulasoglu Ilyas Tuncer 2013Endocrine2013,,1:2
2Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘Akbas F Coskunpinar E Aynaci E 2012Exp Lung Res2012,38,6:1
3The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study 显示文摘Cakmak HA Coskunpinar E Ikitimur B 2015J Cardiovasc Med (Hagerstown)2015,16,6:1
4Investigation of some DNA repair genes association in non small cell lung cancer 显示文摘Coskunpinar E Yildiz P Aynaci E Cellular and Molecular Biology (Noisy-le- Grand France) 20!50,61,8:1
5Analysis of serum micro- RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘Akbas F Coskunpinar E Aynaci E 2012Exp Lung Res2012,38,6:1
6Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘Akbas F Coskunpinar E Aynaci E 2012Exp Lung Res2012,38,:1
7Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘Akbas F Coskunpinar E Aynaci E 2012Exp Lung Res2012,38,6:1
8The prognostic value of circulating microRNAs in heart failure:preliminary results from a genome-wide expression study显示文摘Cakmak HA Coskunpinar E Ikitimur B 2015J Cardiovasc Med2015,16,6:1
9Identification of a dif- ferential expression signature associated with tumorigenesis and metastasis of laryngealcarcinoma显示文摘Coskunpinar E Oltulu YM Orhan KS 2014Gene2014,534,2:1
10ANALYSIS OF SERUM MICRO-RNAs AS POTENTIAL BIOMARKER IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE显示文摘Fahri Akbas Ender Coskunpinar Engin Aynac&inodot Yasemin steri Oltulu Pinar Yildiz 2012Experimental Lung Research2012,,:1
11Analysis of se- rum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘AKBAS F COSKUNPINAR E AYNACI E 2012Exp Lung Res2012,38,6:1
12Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer显示文摘Aynaci E Coskunpinar E Eren A 2013Genet Mol Res2013,12,3:1
13Measurement of constructs using self-report and behavioral lab tasks: Is there overlap in nomothetic span and construct representation for impulsivity?显示文摘Cyders M A Coskunpinar A 2011Clinical Psychology Review2011,31,6:1
14Cyelooxygenase-2 gene and lung carcinoma risk显示文摘Coskunpinar E Eraltan IY Turna A 2011Med Oncol2011,28,4:1
15The relationship between self - re- port and lab task conceptualizations of impulsivity 显示文摘Cyders M A and A Coskunpinar 2012Journal of Re- search in Personality2012,46,1:1
16Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘AIM: To analyze the relationship between the serum lectin-like oxidized low-density lipoprotein receptor-1(LOX-1) levels and clinical and histopathological features of biopsy-confirmed nonalcoholic fatty liver disease(NAFLD) patients.METHODS: Fifty-three consecutive,biopsy-proven NAFLD patients(31 males and 22 females,mean age 42.5 ± 9.6 years) and 26 age- and gender-matched,healthy controls(14 males and 12 females,mean age 39 ± 10.7 years) were included.The patientswith NAFLD were consecutive patients who had been admitted to the hepatology outpatient clinic within the last year and had been diagnosed with NAFLD as the result of liver biopsy.The healthy controls were individuals who attended the outpatient clinic for routine health control and had no known chronic illnesses.The histological evaluation was conducted according t o t he N AF LD ac t ivi ty scoring syst em recommended by The National Institute of Diabetes and Digestive and Kidney Diseases Nonalcoholic Steatohepatitis Clinical Research Network.The serum LOX-1 levels were measured using an ELISA kit(Life Science Inc.USCN.Wuhan,Catalog No.E1859Hu) in both patients and healthy controls.A receiver operating characteristic(ROC) curve analysis was used to identify the optimal cutoff value of LOX-1 and thereby distinguish between patients with nonalcoholic steatohepatitis(NASH) and healthy controls.A P-value < 0.05 was considered statistically significant.RESULTS: NAFLD and healthy control groups were similar in terms of age and sex.NAFLD patients consisted of 8 patients with simple steatosis(15%),27 with borderline NASH(51%) and 18 with definitive NASH(34%).Metabolic syndrome was found in 62.2% of the patients with NAFLD.The mean serum LOX-1 level in biopsy-proven NAFLD patients was 8.49 ± 6.43 ng/m L compared to 4.08 ± 4.32 ng/m L in healthy controls(P = 0.001).The LOX-1 levels were significantly different between controls,simple steatosis and NASH(borderline+definite) cases(4.08 ± 4.32 ng/m L,6.1 ± 6.16 ng/m L,8.92 ± 6.45 ng/m L,respectively,P = 0.004).When the cut-off value for the serum LOX-1 level was set at 5.35 ng/m L,and a ROC curve analysis was performed to distinguish between steatohepatitis patients and controls; the sensitivity and specificity of the serum LOX-1 level were 69.8% and 69.2%,respectively.CONCLUSION: The serum LOX-1 levels were significantly higher in NAFLD patients than in healthy controls.Additionally,the serum LOX-1 levels could differentiate between steatohepatitis patients and healthy controls.Oguzhan Ozturk Yasar Colak Ebubekir Senates Yusuf Yilmaz Celal Ulasoglu Levent Doganay Seyma Ozkanli Yasemin Musteri Oltulu Ender Coskunpinar Ilyas Tuncer 2015World Journal of Gastroenterology2015,21,26:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费